Skip to main content
. 2001 Sep;134(2):353–358. doi: 10.1038/sj.bjp.0704248

Figure 3.

Figure 3

Inhibition of platelet-neutrophil conjugate formation in whole blood in vitro by AR-C69931 (ARC 100 nmol l−1), dipyridamole (dip 10 μmol l−1), aspirin (ASA 100 μmol l−1) and combinations of these. (a) Spontaneous conjugates; (b) with 3 μmol l−1 ADP; (c) with 1 μmol l−1 PAF. The median fluorescence of CD42a positive platelets is shown (mean±s.d.), n=6, *P<0.01.